For the active substances 1-decanol, boscalid, dodine, eugenol, fenpyroximate, fluazinam, fluopyram, geraniol, malathion, prohexadione, proquinazid, pyrethrins and thymol, the Authority needs additional time to reach a conclusion on the risk assessment. Taking into account the subsequent steps to be completed in each renewal procedure, the duration of the extension of the approval periods of these active substances should be set at 19 months and 15 days for fenpyroximate, fluazinam and proquinazid, at 22 months and 15 days for pyrethrins, and at 23 months and 15 days for 1-decanol, boscalid, dodine, eugenol, fluopyram, geraniol, malathion, prohexadione and thymol.
Recital 54, Regulation (EU) 2026/372
In forcesince 20 Feb 2026